繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Checkpoint Therapeutics Unveils Secondary Sale of Securities

2024-08-20 05:39

05:39 PM EDT, 08/19/2024 (MT Newswires) -- Checkpoint Therapeutics (CKPT) disclosed a secondary sale late Monday of up to roughly 5.9 million shares underlying common stock warrants and 351,220 shares underlying placement agent warrants.

The company said the selling shareholders may offer, sell, or distribute the shares at varying prices.

The company will not receive any of the proceeds from the sale.

Company shares were down nearly 5% in after-hours activity.

Price: 2.2100, Change: -0.11, Percent Change: -4.74

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。